Soligenix Announces Reverse Stock Split

/PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Related Keywords

,Us Congress ,Prnewswire Soligenix Inc ,National Institute Of Allergy ,Development Authority ,Twitter ,Linkedin ,Soligenix Inc ,Our Public Health Solutions ,Equiniti Trust Company ,Exchange Commission ,Defense Threat Reduction Agency ,Nasdaq ,Biomedical Advanced Research ,Company Board Of Directors ,Common Stock Will Begin Trading ,Split Adjusted Basis ,Nasdaq Capital Market ,Second Amended ,Restated Certificate ,Public Health Solutions ,National Institute ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,